EA200600989A1 - Применение габоксадола для лечения бессонницы - Google Patents

Применение габоксадола для лечения бессонницы

Info

Publication number
EA200600989A1
EA200600989A1 EA200600989A EA200600989A EA200600989A1 EA 200600989 A1 EA200600989 A1 EA 200600989A1 EA 200600989 A EA200600989 A EA 200600989A EA 200600989 A EA200600989 A EA 200600989A EA 200600989 A1 EA200600989 A1 EA 200600989A1
Authority
EA
Eurasian Patent Office
Prior art keywords
gaboxadol
cerebells
treatment
application
treating insomnia
Prior art date
Application number
EA200600989A
Other languages
English (en)
Inventor
Бьярке Эберт
Йонас Лундаль
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684447&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200600989(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Publication of EA200600989A1 publication Critical patent/EA200600989A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Abstract

Настоящее изобретение касается способа лечения бессонницы у пациента-человека, нуждающегося в этом, путем введения указанному пациенту такого количества габоксадола в день, которое эффективно для лечения бессонницы.
EA200600989A 2003-12-18 2004-12-14 Применение габоксадола для лечения бессонницы EA200600989A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200301877 2003-12-18
PCT/DK2004/000861 WO2005058313A1 (en) 2003-12-18 2004-12-14 Use of gaboxadol for treating insomnia

Publications (1)

Publication Number Publication Date
EA200600989A1 true EA200600989A1 (ru) 2006-10-27

Family

ID=34684447

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600989A EA200600989A1 (ru) 2003-12-18 2004-12-14 Применение габоксадола для лечения бессонницы

Country Status (17)

Country Link
EP (1) EP1720547A1 (ru)
JP (1) JP2007515415A (ru)
KR (1) KR20060103335A (ru)
CN (1) CN1893942A (ru)
AR (1) AR047154A1 (ru)
AU (1) AU2004298313A1 (ru)
BR (1) BRPI0415893A (ru)
CA (1) CA2550610A1 (ru)
EA (1) EA200600989A1 (ru)
IL (1) IL176239A0 (ru)
IS (1) IS8390A (ru)
MX (1) MXPA06006685A (ru)
NO (1) NO20063320L (ru)
SG (1) SG133601A1 (ru)
TW (1) TW200528098A (ru)
WO (1) WO2005058313A1 (ru)
ZA (1) ZA200602762B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0402118D0 (en) 2004-01-30 2004-03-03 Merck Sharp & Dohme Polymorphic forms of a GABAA agonist
US20080262029A1 (en) * 2005-04-29 2008-10-23 H. Lundbeck A/S Acid and Base Salt Forms of Gaboxadol
US20190076409A1 (en) * 2017-09-12 2019-03-14 Ovid Therapeutics Inc. Use of gaboxadol in the treatment of narcolepsy
CA3113644A1 (en) 2018-09-20 2020-03-26 Ovid Therapeutics Inc. Use of gaboxadol for the treatment of tourette syndrome, tics and stuttering
EP3880201A4 (en) 2018-12-17 2022-07-27 Ovid Therapeutics Inc. USE OF GABOXADOL IN THE TREATMENT OF NON-24 HOUR SLEEP waking disorder
AU2020405060A1 (en) 2019-12-18 2022-06-09 Ovid Therapeutics Inc. Gaboxadol for therapeutic treatment of 1p36 deletion syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
HUP0400051A2 (hu) * 2001-05-21 2004-04-28 H. Lundbeck A/S Gabodaxolt tartalmazó granulált készítmények és eljárás az előállításukra

Also Published As

Publication number Publication date
SG133601A1 (en) 2007-07-30
IS8390A (is) 2006-03-30
AR047154A1 (es) 2006-01-11
AU2004298313A1 (en) 2005-06-30
BRPI0415893A (pt) 2007-01-09
ZA200602762B (en) 2007-06-27
CA2550610A1 (en) 2005-06-30
KR20060103335A (ko) 2006-09-28
WO2005058313A1 (en) 2005-06-30
CN1893942A (zh) 2007-01-10
NO20063320L (no) 2006-07-18
IL176239A0 (en) 2006-10-05
MXPA06006685A (es) 2006-08-23
EP1720547A1 (en) 2006-11-15
TW200528098A (en) 2005-09-01
JP2007515415A (ja) 2007-06-14

Similar Documents

Publication Publication Date Title
EA201000914A1 (ru) Новые терапевтические подходы в лечении смт и связанных с ней расстройств
BR0308928A (pt) Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular
MY151032A (en) Treatment of tnf? related disorders
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
CY1109229T1 (el) Χρηση σπογγοσινης (2-μεθοξυαδενοσινης) για τη θεραπεια πονου, συγκεκριμενα υπερευαισθησιας στο πονο
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
BR0308813A (pt) Tratamento de tuberculose usando derivados de pleuromutilina
ATE318135T1 (de) Verwendung von dapoxetin, a selektiver serotonin- aufnahme inhibitor mit schnellem wirkungseintritt,zur behandlung von sexueller dysfunction
SE0400184D0 (sv) New therapeutical use
NO20063320L (no) Anvendelse av gaboxadol for behandling av insomni
DK1030667T3 (da) Anvendelse af mirtazapin til fremstilling af et lægemiddel til behandling af sövnapnö
DK1610864T3 (da) Elektromagnetisk stimulering af patienter med osteoporose
EA200501310A1 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения боли
BR0316132A (pt) Método para estimular o crescimento de cabelo utilizando benzopiranos
DE602004024871D1 (de) Polyamin-verbindungen zur behandlung von chemokin-rezeptor-vermittelten krankheiten
ATE487480T1 (de) Perhexilin zur behandlung von chronischer herzinsuffizienz
EA200601853A1 (ru) Лечение нарушенной дыхательной функции
ATE449607T1 (de) Arsentherapie zur behandlung von autoimmunerkrankungen
MXPA05013975A (es) Tratamiento de enfermedades asociadas con amiloide y epileptogenesis.
ATE486594T1 (de) Methode zur behandlung von herzinsuffizienz
RS52038B (en) USE OF 7-BUTOXYIMINOMETHYLAMPTOTECIN FOR THE TREATMENT OF NON-PLASMA NEOPLASMS
TW200509882A (en) Beauty method
DE60108775T8 (de) Methode zur behandlung von schlaganfall
TW200512183A (en) 2-alkylidene-19-nor-vitamin d derivatives for the treatment of frailty, muscle damage or sarcopenia
DE602004025001D1 (de) Verbindungen zur behandlung von neuropathischen schmerzen und migräne